News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and viewsWrexham nurse wins People’s Choice Award for outstanding commitment to prostate cancer patients
Voted for by her colleagues, patients and their families, Sandie Jones scoops our inaugural award for her extraordinary 20-year career caring for men – from biopsy to post-treatment support. We spoke to her and one of her grateful patients, and find out why we're campaigning for more nurses like Sandie across the UK.
Opening up about the mental toll of prostate cancer and how to cope with it
To mark World Mental Health Day, we're highlighting the often overlooked emotional impacts of prostate cancer. We spoke to men with the disease about their mental health challenges and ask what their, our Specialist Nurses' and your tips are for maintaining your emotional wellbeing.
Reprogramming rogue immune cells to fight prostate cancer
As part of our Research Innovation Awards, we’re funding Professor Claire Lewis at the University of Sheffield to see if it's possible to train men’s own immune systems to fight back at prostate cancer and prevent it from returning. She explains the fascinating 'Trojan horse' science behind this new example of Immunotherapy research.
“What made the chemo side effects tolerable was knowing they'd be good for the film!”
When Jeremy Nicholl was diagnosed with incurable prostate cancer last year, the 60-year-old photographer decided to film himself undergoing treatment with early docetaxel and hormone therapy, releasing them online as a series called My Beautiful Cancer. We talk to him about why the filming helped him cope with his symptoms and what the public reaction has been to his starkly honest videos.
Early research shows immunotherapy's potential for one type of aggressive prostate cancer
The Institute of Cancer Research has discovered a genetic mutation in samples of some men's tumours that could make them particularly susceptible to immunotherapy treatment. The researchers are now committed to running clinical trials to prove if their theory is right.
Largest trial of HIFU focal therapy shows early promise
A five-year early-stage study of high-intensity focused ultrasound resulted in tumour progression being halted in men with intermediate-risk, localised prostate cancer. But more evidence is needed to prove its benefits hold up against existing treatment options and for all men with the disease.
NICE decision on abiraterone could take away best hope for some men with incurable disease
BLOG: Abiraterone should continue to be available on the NHS and opened up to all men with newly diagnosed advanced prostated cancer, argues our policy manager Tim Windle, as the UK’s drug guidelines body is set to rule on the future of the treatment.
New type of immune treatment shows early promise for advanced prostate cancer
An early-stage trial of the immunotherapy drug, pembrolizumab, has proven it to be effective for a small number of men with incurable disease. We take a closer a look at how it works and what we're doing to bring the benefits of immunotherapy to many more men with prostate cancer.
The Manual: What's next after hormone therapy?
Hormone therapy is a treatment that controls rather than cures prostate cancer that has spread, so we’re often asked what’s next if it stops working so well. Our Specialist Nurse, Patricia, looks at the options.
Behind the headlines: Symptoms, screening and PSA – should I have a test?
This week the PSA test is in the media spotlight after results from a large prostate cancer trial were released. So what should men do if they are worried about prostate cancer? Who should have a PSA test? Our Specialist Nurse, Ali Rooke sets out the facts.